Next phase of breast cancer vaccine research begins at Cleveland Clinic

For nearly two decades, Cleveland Clinic researchers have been trying to create a vaccine to prevent the most aggressive and lethal type of breast cancer: Triple negative.

The research will continue despite the loss of the man who started it all.